1 Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
2 First Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA Hospital Thessaloniki, Greece.
3 Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.
4 Department of Blood and Tumour Diseases, Uppsala University Hospital, Uppsala, Sweden.
5 Institute of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
6 Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
7 Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.